Published in Am J Pathol on April 06, 2009
Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination. Acta Neuropathol (2012) 1.53
Adult neural stem cells expressing IL-10 confer potent immunomodulation and remyelination in experimental autoimmune encephalitis. J Clin Invest (2009) 1.38
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of central nervous system diseases. Arch Neurol (2010) 1.08
Neurotrophin 3 transduction augments remyelinating and immunomodulatory capacity of neural stem cells. Mol Ther (2013) 0.98
Activation of PPAR-γ and PTEN cascade participates in lovastatin-mediated accelerated differentiation of oligodendrocyte progenitor cells. Glia (2010) 0.96
Evaluation of bone marrow- and brain-derived neural stem cells in therapy of central nervous system autoimmunity. Am J Pathol (2010) 0.96
Amyloid β1-42 oligomer inhibits myelin sheet formation in vitro. Neurobiol Aging (2010) 0.90
Cell therapy for multiple sclerosis. Neurotherapeutics (2011) 0.89
Statins in traumatic brain injury. Neurotherapeutics (2010) 0.89
Mutation of 3-hydroxy-3-methylglutaryl CoA synthase I reveals requirements for isoprenoid and cholesterol synthesis in oligodendrocyte migration arrest, axon wrapping, and myelin gene expression. J Neurosci (2014) 0.89
Atorvastatin added to interferon β for relapsing multiple sclerosis: a randomized controlled trial. J Neurol (2012) 0.89
Inhibition of interferon-beta responses in multiple sclerosis immune cells associated with high-dose statins. Arch Neurol (2012) 0.85
Molecular mechanisms underlying the effects of statins in the central nervous system. Int J Mol Sci (2014) 0.83
Statins and memory loss: An Australian experience. Australas Med J (2015) 0.81
Coseeded Schwann cells myelinate neurites from differentiated neural stem cells in neurotrophin-3-loaded PLGA carriers. Int J Nanomedicine (2012) 0.81
Atorvastatin added to interferon beta for relapsing multiple sclerosis: 12-month treatment extension of the randomized multicenter SWABIMS trial. PLoS One (2014) 0.80
SWiss Atorvastatin and interferon Beta-1b trial In Multiple Sclerosis (SWABIMS)--rationale, design and methodology. Trials (2009) 0.79
Statin therapy and multiple sclerosis disability in a population-based cohort. Mult Scler (2011) 0.77
Simvastatin-induced cognitive dysfunction: two case reports. J Med Case Rep (2016) 0.76
Statins: a revised appraisal for potential additional future treatment indications. Arthritis Res Ther (2012) 0.75
The impact of fingolimod (FTY720) in neuroimmunologic diseases: mechanisms beyond immunomodulation. Am J Pathol (2010) 0.75
Dietary cholesterol promotes repair of demyelinated lesions in the adult brain. Nat Commun (2017) 0.75
Statin use and cognitive function in middle-aged adults with type 1 diabetes. World J Diabetes (2017) 0.75
Metabolic pathways as possible therapeutic targets for progressive multiple sclerosis. Neural Regen Res (2017) 0.75
The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature (2002) 5.24
Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res Mol Brain Res (1998) 4.87
Oral simvastatin treatment in relapsing-remitting multiple sclerosis. Lancet (2004) 3.95
The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol (2001) 3.47
Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. J Neurosci (2000) 3.40
Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain (2008) 2.83
Drug interactions and the statins. CMAJ (1999) 2.50
High cholesterol level is essential for myelin membrane growth. Nat Neurosci (2005) 2.34
Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination. Mol Cell Neurosci (2004) 1.95
Increased expression of Nkx2.2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS. Mol Cell Neurosci (2004) 1.51
Remyelination in multiple sclerosis. J Neurol Sci (2003) 1.43
Regulation of integrin growth factor interactions in oligodendrocytes by lipid raft microdomains. Curr Biol (2003) 1.43
Progenitor cells derived from the adult human subcortical white matter disperse and differentiate as oligodendrocytes within demyelinated lesions of the rat brain. J Neurosci Res (2002) 1.40
Transcription factor co-expression patterns indicate heterogeneity of oligodendroglial subpopulations in adult spinal cord. Glia (2006) 1.35
Microglial recruitment, activation, and proliferation in response to primary demyelination. Am J Pathol (2007) 1.31
In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors. Pharm Res (1994) 1.28
Lysolecithin-induced demyelination in primates: preliminary in vivo study with MR and magnetization transfer. AJNR Am J Neuroradiol (1995) 1.22
Proliferation and death of oligodendrocytes and myelin proteins are differentially regulated in male and female rodents. J Neurosci (2006) 1.18
Statin effects on cholesterol micro-domains in brain plasma membranes. Biochem Pharmacol (2003) 1.17
Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex. J Pharmacol Exp Ther (2004) 1.16
Multiple sclerosis. Pathology of recurrent lesions. Brain (1993) 1.16
Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions. Ann Neurol (2008) 1.16
HMG-CoA reductase inhibitor augments survival and differentiation of oligodendrocyte progenitors in animal model of multiple sclerosis. FASEB J (2005) 1.11
Negative impact of statins on oligodendrocytes and myelin formation in vitro and in vivo. J Neurosci (2008) 1.10
Lipid rafts and integrin activation regulate oligodendrocyte survival. J Neurosci (2004) 1.10
Alterations in metabolism and gene expression in brain regions during cuprizone-induced demyelination and remyelination. J Neurochem (2002) 1.06
Platelet-derived growth factor-alpha receptor-positive oligodendroglia are frequent in multiple sclerosis lesions. Ann Neurol (2001) 1.00
Blood-brain barrier permeability to horseradish peroxidase in twitcher and cuprizone-intoxicated mice. Brain Res (1987) 1.00
Nogo-A is a reliable oligodendroglial marker in adult human and mouse CNS and in demyelinated lesions. J Neuropathol Exp Neurol (2007) 0.98
Turnover of myelin proteins in mouse brain in vivo. Biochem J (1977) 0.98
Changes in human plasma levels of the brain specific oxysterol 24S-hydroxycholesterol during progression of multiple sclerosis. Neurosci Lett (2002) 0.98
Simvastatin regulates oligodendroglial process dynamics and survival. Glia (2007) 0.97
Lovastatin induces the formation of abnormal myelin-like membrane sheets in primary oligodendrocytes. Glia (2009) 0.94
Statin treatment of adult human glial progenitors induces PPAR gamma-mediated oligodendrocytic differentiation. Glia (2008) 0.89
Lysophosphatidyl choline-induced focal demyelination in the rabbit corpus callosum. Light-microscopic observations. J Neurol Sci (1979) 0.87
Lovastatin induces apoptosis of spontaneously immortalized rat brain neuroblasts: involvement of nonsterol isoprenoid biosynthesis inhibition. Mol Cell Neurosci (2001) 0.87
Effects of the cholesterol biosynthesis inhibitor ay9944 on organotypic cultures ofmouse spinal cord. Retarded myelinogenesis and induction of cytoplasmic inclusions. Lab Invest (1975) 0.87
An in vitro study of the effects of lovastatin on human fetal brain cells. Neurotoxicol Teratol (1995) 0.87
24S-hydroxycholesterol in relation to disease manifestations of acute experimental autoimmune encephalomyelitis. J Neurosci Res (2007) 0.81
Simvastatin induces cell death in a mouse cerebellar slice culture (CSC) model of developmental myelination. Exp Neurol (2008) 0.80
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med (2005) 74.55
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol (2009) 25.96
Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA (2011) 6.92
Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol (2009) 4.88
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study. Lancet Neurol (2012) 3.66
TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol (2005) 2.94
Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J Neurosci (2003) 2.52
Netrins: versatile extracellular cues with diverse functions. Development (2011) 2.29
Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. Cell Stem Cell (2013) 2.22
Natalizumab effects on immune cell responses in multiple sclerosis. Ann Neurol (2006) 2.06
Netrins and their receptors. Adv Exp Med Biol (2007) 1.78
Comparison of polarization properties of human adult microglia and blood-derived macrophages. Glia (2012) 1.73
Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment. J Immunol (2008) 1.58
Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices. Am J Pathol (2010) 1.58
Reduced Treg frequency in LFA-1-deficient mice allows enhanced T effector differentiation and pathology in EAE. Eur J Immunol (2010) 1.58
FTY720 modulates human oligodendrocyte progenitor process extension and survival. Ann Neurol (2008) 1.55
The netrin-1 receptor DCC promotes filopodia formation and cell spreading by activating Cdc42 and Rac1. Mol Cell Neurosci (2002) 1.55
Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination. Acta Neuropathol (2012) 1.53
High frequency of human herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection. J Infect Dis (2003) 1.51
Distinct properties of circulating CD8+ T cells in FTY720-treated patients with multiple sclerosis. Arch Neurol (2010) 1.51
Toll-like receptor 2 signaling in response to brain injury: an innate bridge to neuroinflammation. J Neurosci (2006) 1.49
Longitudinal neuroanatomical changes determined by deformation-based morphometry in a mouse model of Alzheimer's disease. Neuroimage (2008) 1.46
Remyelination in multiple sclerosis. J Neurol Sci (2003) 1.43
Deleted in colorectal cancer binding netrin-1 mediates cell substrate adhesion and recruits Cdc42, Rac1, Pak1, and N-WASP into an intracellular signaling complex that promotes growth cone expansion. J Neurosci (2005) 1.36
IFN-gamma enhances neurogenesis in wild-type mice and in a mouse model of Alzheimer's disease. FASEB J (2008) 1.34
Type 2 monocyte and microglia differentiation mediated by glatiramer acetate therapy in patients with multiple sclerosis. J Immunol (2004) 1.34
Microglia and multiple sclerosis. J Neurosci Res (2005) 1.34
Mammalian motoneuron axon targeting requires receptor protein tyrosine phosphatases sigma and delta. J Neurosci (2006) 1.33
Vulnerability of human neurons to T cell-mediated cytotoxicity. J Immunol (2003) 1.33
Key metalloproteinases are expressed by specific cell types in experimental autoimmune encephalomyelitis. J Immunol (2004) 1.32
Microglial recruitment, activation, and proliferation in response to primary demyelination. Am J Pathol (2007) 1.31
Abeta-induced meningoencephalitis is IFN-gamma-dependent and is associated with T cell-dependent clearance of Abeta in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (2006) 1.30
The tumorigenicity of mouse embryonic stem cells and in vitro differentiated neuronal cells is controlled by the recipients' immune response. PLoS One (2008) 1.29
Central nervous system-directed effects of FTY720 (fingolimod). J Neurol Sci (2008) 1.29
Th1 and Th2 lymphocyte migration across the human BBB is specifically regulated by interferon beta and copolymer-1. J Autoimmun (2005) 1.29
TLR3 deficiency renders astrocytes permissive to herpes simplex virus infection and facilitates establishment of CNS infection in mice. J Clin Invest (2012) 1.24
miR-155 as a multiple sclerosis-relevant regulator of myeloid cell polarization. Ann Neurol (2013) 1.21
A role for interferon-gamma in focal cerebral ischemia in mice. J Neuropathol Exp Neurol (2004) 1.21
The adaptor protein Nck-1 couples the netrin-1 receptor DCC (deleted in colorectal cancer) to the activation of the small GTPase Rac1 through an atypical mechanism. J Biol Chem (2002) 1.21
Receptor protein tyrosine phosphatase sigma inhibits axon regrowth in the adult injured CNS. Mol Cell Neurosci (2005) 1.20
Determinants of human B cell migration across brain endothelial cells. J Immunol (2003) 1.19
Metalloproteinases control brain inflammation induced by pertussis toxin in mice overexpressing the chemokine CCL2 in the central nervous system. J Immunol (2006) 1.17
DCC expression by neurons regulates synaptic plasticity in the adult brain. Cell Rep (2013) 1.13
Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity? Acta Neuropathol (2012) 1.13
The netrin protein family. Genome Biol (2009) 1.12
Cells of the oligodendroglial lineage, myelination, and remyelination. Biochim Biophys Acta (2010) 1.11
ADP and AMP induce interleukin-1beta release from microglial cells through activation of ATP-primed P2X7 receptor channels. J Neurosci (2002) 1.11
Injury-induced type I IFN signaling regulates inflammatory responses in the central nervous system. J Immunol (2010) 1.10
Protein kinase A activation promotes plasma membrane insertion of DCC from an intracellular pool: A novel mechanism regulating commissural axon extension. J Neurosci (2004) 1.10
Developmental shift in expression of netrin receptors in the rat spinal cord: predominance of UNC-5 homologues in adulthood. J Neurosci Res (2004) 1.10
When a diffusible axon guidance cue stops diffusing: roles for netrins in adhesion and morphogenesis. Curr Opin Neurobiol (2006) 1.09
Netrin 1 and Dcc regulate oligodendrocyte process branching and membrane extension via Fyn and RhoA. Development (2009) 1.09
Microglia are required for astroglial Toll-like receptor 4 response and for optimal TLR2 and TLR3 response. Glia (2012) 1.09
Continued administration of ciliary neurotrophic factor protects mice from inflammatory pathology in experimental autoimmune encephalomyelitis. Am J Pathol (2006) 1.09
Correlation of amyloid PET ligand florbetapir F 18 binding with Aβ aggregation and neuritic plaque deposition in postmortem brain tissue. Alzheimer Dis Assoc Disord (2012) 1.08
Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol (2004) 1.08
Rho inhibition recruits DCC to the neuronal plasma membrane and enhances axon chemoattraction to netrin 1. Development (2008) 1.08
NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis. J Neurosci (2007) 1.08
Contribution of astrocyte-derived IL-15 to CD8 T cell effector functions in multiple sclerosis. J Immunol (2010) 1.07
EphA4 is localized in clathrin-coated and synaptic vesicles in adult mouse brain. J Neurochem (2010) 1.07
Glutamate promotes proliferation of striatal neuronal progenitors by an NMDA receptor-mediated mechanism. J Neurosci (2003) 1.07
Molecular control of spinal accessory motor neuron/axon development in the mouse spinal cord. J Neurosci (2005) 1.06
Proliferating resident microglia express the stem cell antigen CD34 in response to acute neural injury. Glia (2005) 1.06
Neuronal ER stress impedes myeloid-cell-induced vascular regeneration through IRE1α degradation of netrin-1. Cell Metab (2013) 1.05
Neutrophils that infiltrate the central nervous system regulate T cell responses. J Immunol (2005) 1.05
Cyclical and dose-dependent responses of adult human mature oligodendrocytes to fingolimod. Am J Pathol (2008) 1.05
CD8+ T cells in inflammatory demyelinating disease. J Neuroimmunol (2007) 1.03
Semi-automated quantification of filopodial dynamics. J Neurosci Methods (2008) 1.03
Intrathecal B-cell clonal expansion, an early sign of humoral immunity, in the cerebrospinal fluid of patients with clinically isolated syndrome suggestive of multiple sclerosis. Lab Invest (2003) 1.03
Reactive microgliosis engages distinct responses by microglial subpopulations after minor central nervous system injury. J Neurosci Res (2005) 1.01
Transgenic mice expressing the p75 CCAAT-displacement protein/Cut homeobox isoform develop a myeloproliferative disease-like myeloid leukemia. Cancer Res (2006) 1.00
Adult spinal cord progenitor cells are repelled by netrin-1 in the embryonic and injured adult spinal cord. Proc Natl Acad Sci U S A (2007) 0.99
Maintenance of axo-oligodendroglial paranodal junctions requires DCC and netrin-1. J Neurosci (2008) 0.99
Isolation of a natural inhibitor of human malignant glial cell invasion: inter alpha-trypsin inhibitor heavy chain 2. Cancer Res (2006) 0.99
What is microglia neurotoxicity (Not)? Glia (2014) 0.99
Cytotoxic NKG2C+ CD4 T cells target oligodendrocytes in multiple sclerosis. J Immunol (2013) 0.99
Soluble adenylyl cyclase is not required for axon guidance to netrin-1. J Neurosci (2008) 0.99
Nogo-A is a reliable oligodendroglial marker in adult human and mouse CNS and in demyelinated lesions. J Neuropathol Exp Neurol (2007) 0.98
Positioned to inhibit: netrin-1 and netrin receptor expression after spinal cord injury. J Neurosci Res (2006) 0.98
Axonal loss and neurofilament phosphorylation changes accompany lesion development and clinical progression in multiple sclerosis. Brain Pathol (2011) 0.98
In toxic demyelination oligodendroglial cell death occurs early and is FAS independent. Neurobiol Dis (2009) 0.98
Differential responses of human microglia and blood-derived myeloid cells to FTY720. J Neuroimmunol (2010) 0.97
Interferons in the central nervous system: a few instruments play many tunes. Glia (2014) 0.97
Rb/E2F regulates expression of neogenin during neuronal migration. Mol Cell Biol (2010) 0.97
Simvastatin regulates oligodendroglial process dynamics and survival. Glia (2007) 0.97